Go Ad-Free
    My Alerts
    Budget Express 2026

    co-presented by

    • JIO BlackRock
    HomeNewsSandu pharma

    Sandu Pharma

    Jump to

    • Sandu Pharma Standalone September 2025 Net Sales at Rs 17.62 crore, down 0.47% Y-o-Y

    • Sandu Pharma Standalone March 2025 Net Sales at Rs 14.07 crore, down 9.8% Y-o-Y

    • Sandu Pharma Consolidated March 2025 Net Sales at Rs 14.07 crore, down 9.8% Y-o-Y

    • Sandu Pharma Consolidated September 2024 Net Sales at Rs 17.70 crore, up 6.61% Y-o-Y

    • Sandu Pharma Standalone September 2024 Net Sales at Rs 17.70 crore, up 6.61% Y-o-Y

    • Sandu Pharma Consolidated June 2024 Net Sales at Rs 17.05 crore, down 3.46% Y-o-Y

    • Sandu Pharma Standalone June 2024 Net Sales at Rs 17.05 crore, down 3.46% Y-o-Y

    • Sandu Pharma Consolidated March 2024 Net Sales at Rs 15.60 crore, up 2.18% Y-o-Y

    • Sandu Pharma Standalone March 2024 Net Sales at Rs 15.60 crore, up 2.18% Y-o-Y

    • Sandu Pharma Consolidated December 2023 Net Sales at Rs 17.43 crore, up 1.97% Y-o-Y

    • Sandu Pharma Standalone December 2023 Net Sales at Rs 17.43 crore, up 1.97% Y-o-Y

    • Sandu Pharma Standalone September 2023 Net Sales at Rs 16.61 crore, down 0.93% Y-o-Y

    • Sandu Pharma Standalone June 2023 Net Sales at Rs 17.66 crore, up 8.8% Y-o-Y

    • Sandu Pharma Standalone March 2023 Net Sales at Rs 15.26 crore, up 33.62% Y-o-Y

    • Sandu Pharma Standalone December 2022 Net Sales at Rs 17.09 crore, down 10.75% Y-o-Y

    • Sandu Pharma Standalone September 2022 Net Sales at Rs 16.76 crore, down 4.7% Y-o-Y

    • Sandu Pharma Standalone December 2021 Net Sales at Rs 19.15 crore, up 21.44% Y-o-Y

    • Sandu Pharma Standalone March 2019 Net Sales at Rs 11.92 crore, down 2.51% Y-o-Y

    • Sandu Pharma Standalone December 2018 Net Sales at Rs 14.19 crore, down 15.05% Y-o-Y

    • Sandu Pharma Standalone September 2018 Net Sales at Rs 12.21 crore, down 30.19% Y-o-Y

    • Sandu Pharma standalone Dec '15 sales at Rs 10.55 crore

      Sandu Pharmaceuticals has reported a sales total income from operations of Rs 10.55 crore and a net profit of Rs 0.22 crore for the quarter ended Dec '15

    • Sandu Pharma standalone Sep '15 sales at Rs 10.46 crore

      Sandu Pharmaceuticals has reported a sales total income from operations of Rs 10.46 crore and a net profit of Rs 0.01 crore for the quarter ended Sep '15

    • Sandu Pharma standalone Jun '15 sales at Rs 8.84 crore

      Sandu Pharmaceuticals has reported a sales total income from operations of Rs 8.84 crore and a net profit of Rs 0.13 crore for the quarter ended Jun '15

    • Sandu Pharma standalone Mar '15 sales at Rs 11.41 crore

      Sandu Pharmaceuticals has reported a standalone total income from operations of Rs 11.41 crore and a net loss of Rs 0.05 crore for the quarter ended Mar '15

    • Sandu Pharma standalone Dec '14 sales at Rs 10.17 crore

      Sandu Pharmaceuticals has reported a sales total income from operations of Rs 10.17 crore and a net profit of Rs 0.20 crore for the quarter ended Dec '14

    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347